ATE314094T1 - Ein komplex aus alpha-fetoprotein (afp) und einem polyungesättigten fettsäurederivat zur behandlung von immunschwäche - Google Patents
Ein komplex aus alpha-fetoprotein (afp) und einem polyungesättigten fettsäurederivat zur behandlung von immunschwächeInfo
- Publication number
- ATE314094T1 ATE314094T1 AT99931090T AT99931090T ATE314094T1 AT E314094 T1 ATE314094 T1 AT E314094T1 AT 99931090 T AT99931090 T AT 99931090T AT 99931090 T AT99931090 T AT 99931090T AT E314094 T1 ATE314094 T1 AT E314094T1
- Authority
- AT
- Austria
- Prior art keywords
- afp
- fetoprotein
- alpha
- complex
- treatment
- Prior art date
Links
- 102000013529 alpha-Fetoproteins Human genes 0.000 title abstract 4
- 108010026331 alpha-Fetoproteins Proteins 0.000 title abstract 4
- 230000007812 deficiency Effects 0.000 title abstract 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 title 1
- -1 N-arachidonoyl aminoethyl phosphate Chemical compound 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000003308 immunostimulating effect Effects 0.000 abstract 1
- 238000011275 oncology therapy Methods 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9802162A SE9802162D0 (sv) | 1998-06-17 | 1998-06-17 | Immunostimulating composition |
| PCT/EP1999/004201 WO1999065936A2 (en) | 1998-06-17 | 1999-06-17 | Composition for the treatement of immune deficiencies and methods for its preparation and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE314094T1 true ATE314094T1 (de) | 2006-01-15 |
Family
ID=20411743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99931090T ATE314094T1 (de) | 1998-06-17 | 1999-06-17 | Ein komplex aus alpha-fetoprotein (afp) und einem polyungesättigten fettsäurederivat zur behandlung von immunschwäche |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6599507B2 (https=) |
| EP (1) | EP1085909B1 (https=) |
| JP (1) | JP4392991B2 (https=) |
| AT (1) | ATE314094T1 (https=) |
| AU (1) | AU748838B2 (https=) |
| BR (1) | BR9911294B1 (https=) |
| CA (1) | CA2335079C (https=) |
| DE (1) | DE69929189T2 (https=) |
| SE (1) | SE9802162D0 (https=) |
| WO (1) | WO1999065936A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9802162D0 (sv) | 1998-06-17 | 1998-06-17 | Nomet Management Services Bv | Immunostimulating composition |
| SE9900941D0 (sv) * | 1998-12-23 | 1999-03-16 | Nomet Management Serv Bv | Novel retinoic acid derivatives and their use |
| CA2358436C (en) * | 1999-03-16 | 2009-03-10 | Ardenia Investments Ltd. | Polyunsaturated fatty acid derivatives and their use |
| US6699851B2 (en) | 2000-07-12 | 2004-03-02 | Ardenia Investments, Ltd. | Cytotoxic compounds and their use |
| US20070111936A1 (en) * | 2005-11-15 | 2007-05-17 | Vladimir Pak | Complex of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096863A (en) * | 1996-08-23 | 2000-08-01 | Regents Of The University Of Minnesota | Self-assembling amphiphiles for construction of peptide secondary structures |
| SE9802162D0 (sv) | 1998-06-17 | 1998-06-17 | Nomet Management Services Bv | Immunostimulating composition |
-
1998
- 1998-06-17 SE SE9802162A patent/SE9802162D0/xx unknown
-
1999
- 1999-06-17 JP JP2000554761A patent/JP4392991B2/ja not_active Expired - Fee Related
- 1999-06-17 EP EP99931090A patent/EP1085909B1/en not_active Expired - Lifetime
- 1999-06-17 AU AU47734/99A patent/AU748838B2/en not_active Ceased
- 1999-06-17 BR BRPI9911294-9A patent/BR9911294B1/pt not_active IP Right Cessation
- 1999-06-17 WO PCT/EP1999/004201 patent/WO1999065936A2/en not_active Ceased
- 1999-06-17 CA CA002335079A patent/CA2335079C/en not_active Expired - Fee Related
- 1999-06-17 DE DE69929189T patent/DE69929189T2/de not_active Expired - Lifetime
- 1999-06-17 AT AT99931090T patent/ATE314094T1/de not_active IP Right Cessation
-
2000
- 2000-12-15 US US09/738,704 patent/US6599507B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2335079C (en) | 2008-01-08 |
| AU748838B2 (en) | 2002-06-13 |
| DE69929189T2 (de) | 2006-08-31 |
| AU4773499A (en) | 2000-01-05 |
| HK1035866A1 (en) | 2001-12-14 |
| EP1085909A2 (en) | 2001-03-28 |
| SE9802162D0 (sv) | 1998-06-17 |
| JP2004500315A (ja) | 2004-01-08 |
| WO1999065936A2 (en) | 1999-12-23 |
| DE69929189D1 (de) | 2006-02-02 |
| US20010034324A1 (en) | 2001-10-25 |
| BR9911294A (pt) | 2002-01-02 |
| WO1999065936A3 (en) | 2000-02-10 |
| EP1085909B1 (en) | 2005-12-28 |
| US6599507B2 (en) | 2003-07-29 |
| BR9911294B1 (pt) | 2012-01-10 |
| CA2335079A1 (en) | 1999-12-23 |
| JP4392991B2 (ja) | 2010-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE321525T1 (de) | Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis | |
| DE69718662D1 (de) | Magnesium(-)hydroxycitrat, verfahren zur herstellung, anwendung und pharmazeutische zusammensetzungen, die sie enthalten | |
| GB9807639D0 (en) | Anti-inflammatory agents | |
| ATE462428T1 (de) | Behandlung von entzündlichen erkrankungen | |
| DE60043692D1 (de) | Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen | |
| ATE125820T1 (de) | Verfahren und zusammensetzungen zur heilung von geschwüren. | |
| DE60000492D1 (de) | Kosmetisches Verfahren zur Haarbehandlung mit Metallpartikeln zur Verbesserung des Haarglanzes | |
| DE59807213D1 (de) | 11beta-halogen-7alpha-substituierte-estratriene, verfahren zur herstellung pharmazeutischer präparate, die diese 11beta-halogen-7alpha-substituierte-estratriene enthalten, sowie deren verwendung zur herstellung von arzneimitteln | |
| DE69424763D1 (de) | Verfahren zur Herstellung von fraktionierten Sojaproteinen und Verwendung desselben in Nahrungsmitteln | |
| ATE330608T1 (de) | Die verwendung von n-phenyl-2-pyrimidine-amine derivaten zur behandlung von entzündlichen erkrankungen | |
| CA2157836A1 (en) | L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses | |
| YU47100A (sh) | Novi derivati dihidroksiheksanoinske kiseline | |
| ATE213939T1 (de) | Verwendung eines gemischs aus einem diol und einer alpha-hydroxysäure zur behandlung hyperkeratotischer hauterkrankungen | |
| ATE172117T1 (de) | Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten | |
| TR200002078T2 (tr) | Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar. | |
| DE69929189D1 (de) | Ein Komplex aus Alpha-Fetoprotein (AFP) und einem polyungesättigten Fettsäurederivat zur Behandlung von Immunschwäche | |
| DE3468021D1 (en) | Imidazol-2-yl mercapto alkanoic acids, process for producing the same and pharmaceutical preparations containing the same | |
| DE69130679D1 (de) | Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation | |
| ATE223721T1 (de) | Edelfosin zur behandlung von hirntumoren | |
| DE69838553D1 (de) | Verfahren zur diagnose, prognose und behandlung von glaukom und verwandten erkrankungen | |
| DE60115523D1 (de) | Verfahren zur Herstellung von Wasserlöslichen Polysacchariden und zur Aufklärung von wässerigen lösungen die sie enthalten | |
| DE69932922D1 (de) | Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen | |
| ATE332905T1 (de) | Verfahren zur herstellung von acylphosphinoxiden | |
| ES8302016A1 (es) | Procedimiento para tratar fracciones individuales de plasma sanguineo. | |
| DK0538330T3 (da) | Beta-Alethin-anvendelse til celledyrkning og terapi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |